# Methods for Conjugating Antibodies with Quantum Dots

**Authors:** Pavel Sokolov, Alexander Knysh, Irina Kriukova, Pavel Samokhvalov, Yury V. Kistenev

PMC · DOI: 10.3390/molecules30193999 · 2025-10-06

## TL;DR

This review discusses methods for attaching antibodies to quantum dots to detect disease markers with high sensitivity and specificity.

## Contribution

The paper provides a comprehensive analysis of current antibody conjugation methods with quantum dots and highlights future research directions.

## Key findings

- Quantum dot–antibody conjugates offer high sensitivity and specificity for detecting disease markers.
- Site-specific and site-nonspecific conjugation methods are reviewed with a focus on structural features.
- Applications in diagnosis, environmental monitoring, and food safety are highlighted.

## Abstract

Nanomaterials are increasingly used in the development of detection systems for various disease biomarkers as tools for reliable early diagnosis, which is a key factor in reducing mortality and increasing treatment effectiveness. The use of quantum dot–antibody conjugates allows for optical detection of various disease markers in biological fluids, tissues, and individual cells with high sensitivity and specificity. The sensitivity and specificity of detection are determined not only by the outstanding optical properties of fluorescent quantum dots but also by the type of antibodies used for binding target analytes and the methods of their conjugation with quantum dots. This review deals with methods of site-specific and site-nonspecific conjugation of quantum dots with antibodies, including full-length and single-domain antibodies, as well as antibody fragments, with a special focus on their structural features and active moieties used for binding to their targets. The review includes examples of successful applications of quantum dot–conjugated antibodies in diagnosis, environment monitoring, and food safety assessment. We also discuss the prospects of further research in this field, including new conjugation methods and issues related to the stability and specificity of probes. The review provides a comprehensive analysis of the current methods and achievements in antibody conjugation from the viewpoint of subsequent analyte detection, highlighting the importance of further research for improving the existing technologies.

## Full-text entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 281004], CNTF (ciliary neurotrophic factor) [NCBI Gene 1270] {aka HCNTF}, Ighg1 (immunoglobulin heavy constant gamma 1 (G1m marker)) [NCBI Gene 16017] {aka IgG1, Igh-4, VH7183}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, CEACAM3 (CEA cell adhesion molecule 3) [NCBI Gene 1084] {aka CD66D, CEA, CGM1, CGM1a, W264, W282}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}, GABBR1 (gamma-aminobutyric acid type B receptor subunit 1) [NCBI Gene 2550] {aka GABABR1, GABBR1-3, GB1, GPRC3A, NEDLC}, MBP (myelin basic protein) [NCBI Gene 618684], ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, F5 (coagulation factor V) [NCBI Gene 2153] {aka FVL, PCCF, RPRGL1, THPH2, fV}, Ighv1-9 (immunoglobulin heavy variable 1-9) [NCBI Gene 668478] {aka Gm16697, Igg2a}, MBP (myelin basic protein) [NCBI Gene 4155], SPINT3 (serine peptidase inhibitor, Kunitz type 3) [NCBI Gene 100296926] {aka ELP}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, PLAUR (plasminogen activator, urokinase receptor) [NCBI Gene 5329] {aka CD87, U-PAR, UPAR, URKR}, ALB (albumin) [NCBI Gene 280717], Igh-V7183 (immunoglobulin heavy chain (V7183 family)) [NCBI Gene 16059] {aka B9-scFv, IgG, IgH, IgVH1(VSG), VH7183, VI24H}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, GPR78 (G protein-coupled receptor 78) [NCBI Gene 27201], CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}
- **Diseases:** cancer (MESH:D009369), oncological, neurodegenerative, infectious, and other diseases (MESH:D019636), injury to (MESH:D014947), breast tumors (MESH:D001943)
- **Chemicals:** histidine (MESH:D006639), PEG (MESH:D011092), azides (MESH:D001386), carboxylic acid (MESH:D002264), TA (MESH:D013635), glycans (MESH:D011134), polymer (MESH:D011108), polyacrylamide (MESH:C016679), Bpa (MESH:C488060), p-acetylphenylalanine (MESH:C476995), dibenzylcyclooctyne (MESH:C000712211), AFB1 (MESH:D016604), gold (MESH:D006046), metal (MESH:D008670), ZnSe (MESH:C044696), isocyanates (MESH:D017953), thioether (MESH:D013440), ZnS (MESH:D015032), tris(2-carboxyethyl) phosphine (MESH:C080938), sodium sulfite (MESH:C025026), periodate (MESH:C009288), P (MESH:D010758), SDS (MESH:D012967), norbornene (MESH:C046060), biotin (MESH:D001710), DTT (MESH:D004229), glycine (MESH:D005998), cadaverine (MESH:D002103), aldehyde (MESH:D000447), galactose (MESH:D005690), p-azido-phenylalanine (MESH:C027162), amide (MESH:D000577), imidazole (MESH:C029899), Tyrosine (MESH:D014443), water (MESH:D014867), poly(acrylic acid) (MESH:C006903), carbodiimide (MESH:D002234), BS3 (MESH:C035760), Nucleotide (MESH:D009711), urea (MESH:D014508), Amino Acids (MESH:D000596), CdTe (MESH:C028337), sulfhydryl (MESH:D013438), VPGVG (MESH:C094883), Carbohydrates (MESH:D002241), Sodium cyanoborohydride (MESH:C009282), Alexa Fluor 488 (MESH:C000711379), N-hydroxysulfosuccinimide (MESH:C035761), 2-ME (MESH:D008623), NH2 (MESH:D000588), trifluoroacetic acid (MESH:D014269), maltose (MESH:D008320), sulfur (MESH:D013455), HgxCd1-xSe (-), ethanolamine (MESH:D019856), Tetracycline (MESH:D013752), Disulfide (MESH:D004220), Alexa Fluor 647 (MESH:C569686), oligosaccharides (MESH:D009844), sulfo-SMCC (MESH:C071675)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Sus scrofa (pig, species) [taxon 9823], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Finegoldia magna (species) [taxon 1260], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Bos taurus (bovine, species) [taxon 9913], Oryza sativa (Asian cultivated rice, species) [taxon 4530]
- **Mutations:** asparagine residue 297, glutamine residues at positions 295, lysine residues with cysteine, Cys for Ser35
- **Cell lines:** CA19-9 — Homo sapiens (Human), Huntington's disease, Induced pluripotent stem cell (CVCL_VC90), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), KPL-4 — Homo sapiens (Human), Breast inflammatory carcinoma, Cancer cell line (CVCL_5310), CHO — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_0213), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12526299/full.md

---
Source: https://tomesphere.com/paper/PMC12526299